New sequencer @BIOASTER

BIOASTER is pleased to announce the recent acquisition of the newest GridION, a sequencer of third generation entirely developed by Oxford Nanopore Technologies. This installation is the logical consequence of...

ERA4TB:Progess and Achievements

BIOASTER is proud to be part of ERA4TB (European Regimen Accelerator for #Tuberculosis) project, a public-private initiative devoted to accelerating the development of new treatment regimens for tuberculosis. The ERA4TB...

Certified Laboratory of biocrates for BIOASTER

Our OMIC team successfully completed Biocrates training and is now part of the certified laboratories able to handle this technology (Certified laboratories – biocrates life sciences ag). High quality metabolomic...

Meet us there!

Meet our Diagnotics and Antimicrobials’s teams at BioFIT Life sciences partnering conference  from December 12th to 13th at Marseille, France.